Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1954 1
1965 1
1970 1
1975 1
1978 1
1979 1
1981 9
1982 11
1983 13
1984 18
1985 16
1986 7
1987 2
1988 2
1990 1
1991 1
1993 5
1994 1
1995 3
2001 1
2003 1
2004 3
2005 1
2006 1
2007 3
2008 2
2009 5
2010 4
2011 3
2012 4
2013 13
2014 10
2015 11
2016 15
2017 6
2018 6
2019 8
2020 13
2021 18
2022 22
2023 20
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

253 results

Results by year

Filters applied: . Clear all
Page 1
Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma.
Verkleij CPM, Broekmans MEC, van Duin M, Frerichs KA, Kuiper R, de Jonge AV, Kaiser M, Morgan G, Axel A, Boominathan R, Sendecki J, Wong A, Verona RI, Sonneveld P, Zweegman S, Adams HC, Mutis T, van de Donk NWCJ. Verkleij CPM, et al. Among authors: de jonge av. Blood Adv. 2021 Apr 27;5(8):2196-2215. doi: 10.1182/bloodadvances.2020003805. Blood Adv. 2021. PMID: 33890981 Free PMC article.
Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment.
van der Horst HJ, de Jonge AV, Hiemstra IH, Gelderloos AT, Berry DRAI, Hijmering NJ, van Essen HF, de Jong D, Chamuleau MED, Zweegman S, Breij ECW, Roemer MGM, Mutis T. van der Horst HJ, et al. Among authors: de jonge av. Blood Cancer J. 2021 Feb 18;11(2):38. doi: 10.1038/s41408-021-00430-6. Blood Cancer J. 2021. PMID: 33602901 Free PMC article.
A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients.
de Jonge AV, van Werkhoven E, Dinmohamed AG, Nijland M, Zwinderman AH, Bossuyt PM, Veldhuis MS, Rutten EGGM, Mous R, Vermaat JSP, Sandberg Y, de Jongh E, Bilgin YM, Boersma R, Koene H, Kersten MJ, de Jong D, Chamuleau MED. de Jonge AV, et al. Blood Cancer J. 2023 May 22;13(1):85. doi: 10.1038/s41408-023-00854-2. Blood Cancer J. 2023. PMID: 37217463 Free PMC article.
Midwifery care is evidence-based but under increasing pressure.
Maimburg RD, Declercq ER, de Jonge A. Maimburg RD, et al. Among authors: de jonge a. Sex Reprod Healthc. 2023 Jun;36:100858. doi: 10.1016/j.srhc.2023.100858. Epub 2023 May 16. Sex Reprod Healthc. 2023. PMID: 37209445 No abstract available.
'Watchful attendance' during labour and birth.
de Jonge A, Dahlen H, Downe S. de Jonge A, et al. Sex Reprod Healthc. 2021 Jun;28:100617. doi: 10.1016/j.srhc.2021.100617. Epub 2021 Mar 19. Sex Reprod Healthc. 2021. PMID: 33774268 Free article. No abstract available.
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates.
Chen EC, Gandler H, Tošić I, Fell GG, Fiore A, Pozdnyakova O, DeAngelo DJ, Galinsky I, Luskin MR, Wadleigh M, Winer ES, Leonard R, O'Day K, de Jonge A, Neuberg D, Look AT, Stone RM, Frank DA, Garcia JS. Chen EC, et al. Among authors: de jonge a. Clin Cancer Res. 2023 Mar 1;29(5):878-887. doi: 10.1158/1078-0432.CCR-22-2540. Clin Cancer Res. 2023. PMID: 36534523 Free PMC article.
More home births during the COVID-19 pandemic in the Netherlands.
Verhoeven CJM, Boer J, Kok M, Nieuwenhuijze M, de Jonge A, Peters LL. Verhoeven CJM, et al. Among authors: de jonge a. Birth. 2022 Dec;49(4):792-804. doi: 10.1111/birt.12646. Epub 2022 May 12. Birth. 2022. PMID: 35554962 Free PMC article.
253 results